<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15372/SSMJ20200401</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-446</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Применение цитокинов в лечении воспалительных и дистрофических заболеваний роговой оболочки (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>The use of cytokines in the treatment of cornea inflammatory and dystrophic diseases (review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2696-7183</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дениско</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisko</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марьяна Сергеевна Дениско</p></bio><bio xml:lang="en"><p>Maryana S. Denisko</p></bio><email xlink:type="simple">m.s.sharova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7509-5858</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кривошеина</surname><given-names>О. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Krivosheina</surname><given-names>O. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Ивановна Кривошеина, д.м.н., профессор</p></bio><bio xml:lang="en"><p>Olga I. Krivosheina, doctor of medical sciences, professor</p></bio><email xlink:type="simple">oikr@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian Medical State University of Minzdrav of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>27</day><month>08</month><year>2020</year></pub-date><volume>40</volume><issue>4</issue><fpage>4</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дениско М.С., Кривошеина О.И., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Дениско М.С., Кривошеина О.И.</copyright-holder><copyright-holder xml:lang="en">Denisko M.S., Krivosheina O.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/446">https://sibmed.elpub.ru/jour/article/view/446</self-uri><abstract><p>Цитокины – уникальные биологически активные вещества, образующие систему регуляции основных функций организма, которая одновременно с нервной и эндокринной системами обеспечивает поддержание гомеостаза при наступлении неблагоприятных условий – внедрении патогенов или нарушении целостности тканей. Цитокины регулируют амплитуду и продолжительность воспалительного и иммунного ответа, в связи с чем продуцируются и секретируются транзиторно и имеют короткий полупериод жизни. Особенностью данных биологически активных веществ является сложность взаимодействия между различными представителями этого класса медиаторов. При этом основными свойствами цитокинов являются плейотропность, отсутствие антигенной специфичности и способность к формированию каскадной цепи, что позволяет разносторонне корригировать спектр репаративных процессов. В последние десятилетия появляются данные о возможности применения цитокинов в регенерации поврежденных тканей, в связи с чем определяется новый вектор поиска патогенетически направленных способов улучшения и восстановления утраченных функций с использованием как отдельных представителей цитокинов, так и их естественного комплекса. В статье представлены основные сведения об участии цитокинов в патогенезе различных по этиологии заболеваний роговицы, а также проведен анализ эффективности цитокинотерапии при патологии роговой оболочки воспалительного и дистрофического характера.</p></abstract><trans-abstract xml:lang="en"><p>Cytokines are unique biologically active substances that form the system of regulation of basic body functions that simultaneously with the nervous and endocrine systems maintain homeostasis under adverse conditions – the introduction of pathogens or violation of the integrity of tissues. Cytokines regulate the amplitude and duration of inflammatory and immune responses, so they are produced and secreted transiently and have a short half-life. These biologically active substances act in very low concentrations. At the same time, the main properties of cytokines are pleiotropy, lack of antigenic specificity, and the ability to form a cascade chain, that allows versatile correction of the spectrum of reparative processes. There are evidences of the possibility of using cytokines in the regeneration of damaged tissues in recent decades. In this connection, a new vector of search for pathogenetically directed ways to improve and restore lost functions using both individual representatives of cytokines and their natural complex is determined. The article reflects the basic information about the influence of cytokines on the development of various diseases of the cornea, as well as the methods of cytokine therapy in the treatment of these pathologies and prospects for their development.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цитокины</kwd><kwd>интерлейкины</kwd><kwd>кератиты</kwd><kwd>аутологичные мононуклеарные лейкоциты</kwd><kwd>репаративная регенерация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cytokines</kwd><kwd>interleukins</kwd><kwd>keratitis</kwd><kwd>mononuclear cells</kwd><kwd>reparative regeneration</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке гранта № 13108ГУ/2018 Фонда содействия инновациям «УМНИК 2018».</funding-statement><funding-statement xml:lang="en">Our research was supported by Foundation for Assistance to Small Innovative Enterprises «UMNIK 2018».</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кетлинский С.А., Симбирцев А.С. Цитокины. СПб.: Фолиант, 2008. 552 с.</mixed-citation><mixed-citation xml:lang="en">Ketlinkii S.A., Simbirtsev А.S. Cytokines. Saint-Petersburg: Foliant; 2008. 552 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ковальчук Л.В., Игнатьева Г.А., Ганковская Л.В. Иммунология. Практикум. М.: ГЭОТАР-Медиа, 2014. 176 с.</mixed-citation><mixed-citation xml:lang="en">Koval’chuk L.V., Ignat’eva G.A., Gankovskaya L.V. Immunology workshop tutorial. Moskow: GEOTAR-Media, 2014. 176 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Сибиряк С.В., Черешнев В.А., Симбирцев А.С., Сибиряк Д.С., Гаврилова Т.В. Цитокиновая регуляция биотрансформации ксенобиотиков и эндогенных соединений. Екатеринбург: УрО РАН, 2006. 148 с.</mixed-citation><mixed-citation xml:lang="en">Sibiryak S.V., Chereshnev V.A., Simbirtsev A.S., Sibiryak D.S., Gavrilova T.V. Cytokine regulation of biotransformation of xenobiotics and endogenous compounds. Ekaterinburg: UrO RAN, 2006. 148 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Хаитов Р.М. Иммунология: учебник для вузов. 2-е изд. М.: ГЭОТАР-Медиа, 2013. 528 с.</mixed-citation><mixed-citation xml:lang="en">Khaitov R.M. Immunology: Тextbook for universities. 2nd edition. Moskow: GEOTAR-Media, 2013. 528 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Симбирцев А.С. Цитокины – новая система регуляции защитных реакций организма. Цитокины и воспаление. 2002; 1 (1): 9–16.</mixed-citation><mixed-citation xml:lang="en">Simbirtsev A.S. Cytokines as a new system, regulating body defense reactions. Tsitokiny i vospalenie = Cytokines and Inflammation. 2002; 1 (1): 9–16. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Симбирцев А.С. Иммунофармакологические аспекты системы цитокинов. Бюл. сиб. мед. 2019; 18 (1): 84–95. doi: 10.20538/1682-0363-2019-1-84–95</mixed-citation><mixed-citation xml:lang="en">Simbirtsev A.S. Immunopharmacological aspects of the cytokine system. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2019; 18 (1): 84–95. doi: 10.20538/1682-0363-2019-1-84–95 [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Носик Н.Н. Цитокины при вирусных инфекциях. Вопр. вирусологии. 2000; 45 (1): 4–10.</mixed-citation><mixed-citation xml:lang="en">Nosik N.N. Cytokines in viral infections. Voprosy virusologii = Problems of Viorology. 2000; 45 (1): 4–10. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Бикбов М.М., Шевчук Н.Е. Цитокины в клинической офтальмологии. Уфа, 2008. 152 c.</mixed-citation><mixed-citation xml:lang="en">Bikbov M.M., Shevchuk N.E. Cytokines in clinical ophthalmology. Ufa, 2008. 152 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Симбирцев А.С. Цитокины в патогенезе и лечении заболеваний человека. СПб.: Фолиант, 2018, 512 c.</mixed-citation><mixed-citation xml:lang="en">Simbirtsev A.S. Cytokines in the pathogenesis and therapy of human diseases. St. Petersburg: Foliant Publ., 2018. 512 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fessler M.B., Malcolm K.C., Duncan M.W., Worthen G.S. Agenomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p 38 mitogen activated protein kinase. J. Biol. Chem. 2002; 277 (35): 31291–31302. doi:10.1074/jbc.m200755200</mixed-citation><mixed-citation xml:lang="en">Fessler M.B., Malcolm K.C., Duncan M.W., Worthen G.S. Agenomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p 38 mitogen activated protein kinase. J. Biol. Chem. 2002; 277 (35): 31291–31302. doi:10.1074/jbc.m200755200</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wang D., Zhang B., Shi H., Yang W., Bi M.C., Song X.F., Zhang C., Cheng J.H., Hao J.L., Song E. Effect of endothelial progenitor cells derived from human umbilical cord blood on oxygen-induced retinopathy in mice by intravitreal transplantation. Int. J. Ophthalmol. 2016; 9 (11): 1578–1583. doi: 10.18240/ijo.2016.11.07</mixed-citation><mixed-citation xml:lang="en">Wang D., Zhang B., Shi H., Yang W., Bi M.C., Song X.F., Zhang C., Cheng J.H., Hao J.L., Song E. Effect of endothelial progenitor cells derived from human umbilical cord blood on oxygen-induced retinopathy in mice by intravitreal transplantation. Int. J. Ophthalmol. 2016; 9 (11): 1578–1583. doi: 10.18240/ijo.2016.11.07</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Xi X., McMillan D.H., Lehmann G.M., Sime P.J., Libby R.T., Huxlin K.R., Feldon S.E., Phipps R.P. Ocular fibroblast diversity: Implications for inflammation and ocular wound healing. Invest. Ophthalmol. Vis. Sci. 2011; 52 (7): 4859–4865. doi:10.1167/iovs.10-7066</mixed-citation><mixed-citation xml:lang="en">Xi X., McMillan D.H., Lehmann G.M., Sime P.J., Libby R.T., Huxlin K.R., Feldon S.E., Phipps R.P. Ocular fibroblast diversity: Implications for inflammation and ocular wound healing. Invest. Ophthalmol. Vis. Sci. 2011; 52 (7): 4859–4865. doi:10.1167/iovs.10-7066</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Слепова О.С. Патогенетическая роль цитокинов при различных заболеваниях глаз как основа для прогнозирования и выбора тактики иммунокорригирующего лечения. Рос. офтальмол. журн. 2008; (3): 36–42.</mixed-citation><mixed-citation xml:lang="en">Slepova O.S. Pathogenetic role of cytokines in various eye diseases as a basis for the prediction and choice of tactics of immunocorrective treatment. Rosiiskiy oftal’mologicheskiy zhurnal = Russian Ophthalmological Journal. 2008; (3): 36–42. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Гринев А.Г. Послеоперационное воспаление в хирургии катаракты с интраокулярной коррекцией. Вестн. офтальмологии. 2003; (2): 47–50.</mixed-citation><mixed-citation xml:lang="en">Grinev A.G. Postoperative inflammation in cata­ract surgery with intraocular correction. Vestnik oftal’­mologii = The Russian Annals of Ophthalmology. 2003; (2): 47–50. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lam D.L., Axtelle J., Rath S., Dyer A., Harrison B., Rogers C., Menon N., van Gelder R.N. A rayleigh scatterbased ocular flare analysis meter for flare photometry of the anterior chamber. Translat. Vis. Sci. Technol. 2015; 4 (6): 7. doi: 10.1167/tvst.4.6.7</mixed-citation><mixed-citation xml:lang="en">Lam D.L., Axtelle J., Rath S., Dyer A., Harrison B., Rogers C., Menon N., van Gelder R.N. A rayleigh scatterbased ocular flare analysis meter for flare photometry of the anterior chamber. Translat. Vis. Sci. Technol. 2015; 4 (6): 7. doi: 10.1167/tvst.4.6.7</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Galvis V., Sherwin T., Tello A., Merayo J., Barrera R., Acera A. Keratoconus: an inflammatory disorder? Eye. 2015; 29 (7): 843–859. doi: 10.1038/eye.2015.63</mixed-citation><mixed-citation xml:lang="en">Galvis V., Sherwin T., Tello A., Merayo J., Barrera R., Acera A. Keratoconus: an inflammatory disorder? Eye. 2015; 29 (7): 843–859. doi: 10.1038/eye.2015.63</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L., Zhang Z., Koch D.D., Jia Y., Cao W., Zhang S. Anterior chamber interleukin 1beta, interleukin 6 and prostaglandin E2 in patients undergoing femtosecond laser-assisted cataract surgery. Brit. J. Ophthalmol. 2016; 100 (4): 579–582. doi: 10.1136/bjophthalmol-2015-307586</mixed-citation><mixed-citation xml:lang="en">Wang L., Zhang Z., Koch D.D., Jia Y., Cao W., Zhang S. Anterior chamber interleukin 1beta, interleukin 6 and prostaglandin E2 in patients undergoing femtosecond laser-assisted cataract surgery. Brit. J. Ophthalmol. 2016; 100 (4): 579–582. doi: 10.1136/bjophthalmol-2015-307586</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma R.K., Rogojina A.T., Chalam K.V. Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol. Vis. 2009; 15: 60–69.</mixed-citation><mixed-citation xml:lang="en">Sharma R.K., Rogojina A.T., Chalam K.V. Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol. Vis. 2009; 15: 60–69.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tzovolou D.N., Lamari F., Mela E.K., Gartaganis S.P., Karamanos N.K. Capillary electrophoretic analysis of brimonidine in aqueous humor of the eye and blood sera and relation of its levels with intraocular pressure. Biomed. Chromatogr. 2000; 14 (5): 301–305. doi: 10.1002/1099-0801(200008) 14:5&lt;301::AID-BMC4&gt;</mixed-citation><mixed-citation xml:lang="en">Tzovolou D.N., Lamari F., Mela E.K., Gartaganis S.P., Karamanos N.K. Capillary electrophoretic analysis of brimonidine in aqueous humor of the eye and blood sera and relation of its levels with intraocular pressure. Biomed. Chromatogr. 2000; 14 (5): 301–305. doi: 10.1002/1099-0801(200008) 14:5&lt;301::AID-BMC4&gt;</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">0.CO;2-Q</mixed-citation><mixed-citation xml:lang="en">0.CO;2-Q</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Шаимова В.А. Роль провоспалительных цитокинов при заболеваниях глаз. Цитокины и воспаление. 2005; 4 (2): 13–15.</mixed-citation><mixed-citation xml:lang="en">Shaimova V.A. The role of proinflammatory cytokines in eye diseases. Tsitokiny i vospalenie = Cytokines and Inflammation. 2005; 4 (2): 13–15. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Biswas P.S., Banerjee K., Zheng M., Rouse B.T. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J. Leukoc. Biol. 2004; 76 (4): 868–875. doi: 10.1189/jlb.0504280</mixed-citation><mixed-citation xml:lang="en">Biswas P.S., Banerjee K., Zheng M., Rouse B.T. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J. Leukoc. Biol. 2004; 76 (4): 868–875. doi: 10.1189/jlb.0504280</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Biswas P.S. IL-17 in Renal Immunity and Autoimmunity. J. Immunol. 2018; 201 (11): 3153–3159. doi: 10.4049/jimmunol.1801042</mixed-citation><mixed-citation xml:lang="en">Biswas P.S. IL-17 in Renal Immunity and Autoimmunity. J. Immunol. 2018; 201 (11): 3153–3159. doi: 10.4049/jimmunol.1801042</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Каспаров А.А. Локальная экспресс-аутоцитокинотерапия (комплекс цитокинов) в лечении вирусных и невирусных поражений глаз. Вестн. офтальмологии. 2001; (3): 45–47.</mixed-citation><mixed-citation xml:lang="en">Kasparov A.A. Local Express autocatakinetic (complex of cytokines) in thetreatment of viral and non-virallesions of the eye. Vestnik oftal’mologii = The Russian Annals of Ophthalmology. 2001; (3): 45–47. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Каспарова Е.А., Фадеева Л.Л., Павлюк А.С., Переверзина О.К., Каспаров А.А. К вопросу о теоретическом обосновании методики локальной экспресс-аутоцитокинотерапии. Вестн. офтальмологии. 2002; (3): 25–27.</mixed-citation><mixed-citation xml:lang="en">Kasparova E.A., Fadeeva L.L., Pavlyuk A.S., Pere­verzina O.K., Kasparov A.A. To the question about the theoretical justification of methods local express autocatakinetic. Vestnik oftal’mologii = The Russian Annals of Ophthalmology. 2002; (3): 25–27. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Елегечева О.Н., Кривошеина О.И., Запускалов И.В. Применение аутологичных мононуклеаров крови в комплексном лечении язв роговицы. Вестн. офтальмологии. 2008; (5): 32–35.</mixed-citation><mixed-citation xml:lang="en">Elegecheva O.N., Krivosheina O.I., Zapuskalov I.V. Use of autologous blood mononuclear cells in the complex treatment of corneal ulcers. Vestnik oftal’mologii = The Russian Annals of Ophthalmology. 2008; (5): 32–35. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Елегечева О.Н., Кривошеина О.И., Запускалов И.В. Лечение экспериментальной язвы роговицы с помощью аутологичных мононуклеаров. Новые технологии в офтальмологии: мате­риалы Междунар. науч.-практ. конф. Казань, 2008. 116–119.</mixed-citation><mixed-citation xml:lang="en">Elegecheva O.N., Krivosheina O.I., Zapuskalov I.V. The treatment of experimental ulcers of the cornea by autologous mononuclear cells. New technologies in ophthalmology. Materials of the international scientific and practical conference. Kazan, 2008. 116–119. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Левченко Н.А., Запускалов И.В., Кривошеина О.И. Динамика воспалительно-регенераторных процессов при экспериментальной язве роговицы на фоне применения аутологичных мононуклеаров крови. Бюл. сиб. мед. 2011; (1): 38–42.</mixed-citation><mixed-citation xml:lang="en">Levchenko N.A., Zapuskalov I.V., Krivosheina O.I. Dynamics of inflammatory and regenerative processes in experimental corneal ulcer on the background of autologous blood mononuclears. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2011; (1): 38–42. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Левченко Н.А., Кривошеина О.И. Влияние аутологичных мононуклеаров крови на регенераторные процессы при стромальных повреждениях роговицы в эксперименте. Бюл. сиб. мед. 2011; (4): 27–31. doi: 10.20538/1682-0363-2011-4-27-31</mixed-citation><mixed-citation xml:lang="en">Levchenko N.A., Krivosheina O.I. The effect of autologous blood mononuclear cells in regenerative processes in the stromal damage in the cornea in the experiment. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2011; (4): 27–31. doi: 10.20538/1682-0363-2011-4-27-31 [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Левченко Н.А., Кривошеина О.И., Запускалов И.В. Оценка клинической эффективности интрастромального введения аутологичных мононуклеаров крови в лечении герпетических язвенных кератитов. Актуальные проблемы офтальмологии: сб. науч. работ VI Всерос. науч. конф. молодых ученых. М., 2011. 173–174.</mixed-citation><mixed-citation xml:lang="en">Levchenko N.A., Krivosheina O.I., Zapuskalov I.V. Evaluation of clinical efficacy of intrastromal administration of autologous blood mononuclears in the treatment of herpetic ulcerative keratitis. Actual problems of ophthalmology: сollection of scientific works of VI all-Russian scientific conference of young scientists. Moscow, 2011. 173–174. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Karthikeyan R.S., Vareechon C., Prajna N.V., Dharmalingam K., Pearlman E., Lalitha P. IL-17 expression in peripheral blood neutrophils from fungal keratitis patients and healthy cohorts in south India. J. Infect. Dis. 2015; 211 (1): 130–134. doi: 10.1093/infdis/jiu381</mixed-citation><mixed-citation xml:lang="en">Karthikeyan R.S., Vareechon C., Prajna N.V., Dharmalingam K., Pearlman E., Lalitha P. IL-17 expression in peripheral blood neutrophils from fungal keratitis patients and healthy cohorts in south India. J. Infect. Dis. 2015; 211 (1): 130–134. doi: 10.1093/infdis/jiu381</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor P.R., Roy S., Meszaros E.C., Sun Y., Howell S.J., Malemud C.J., Pearlman E. JAK/STAT regulation of Aspergillus fumigatus corneal infections and IL-6/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity. J. Leukoc. Biol. 2016; 100 (1): 213–222. doi: 10.1189/jlb.4A1015-483R</mixed-citation><mixed-citation xml:lang="en">Taylor P.R., Roy S., Meszaros E.C., Sun Y., Howell S.J., Malemud C.J., Pearlman E. JAK/STAT regulation of Aspergillus fumigatus corneal infections and IL-6/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity. J. Leukoc. Biol. 2016; 100 (1): 213–222. doi: 10.1189/jlb.4A1015-483R</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Suryawanshi A., Veiga-Parga T., Reddy P.B., Rajasagi N.K., Rouse B.T. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J. Immunol. 2012; 188 (7): 3434–3446. doi: 10.4049/jimmunol.1102602</mixed-citation><mixed-citation xml:lang="en">Suryawanshi A., Veiga-Parga T., Reddy P.B., Rajasagi N.K., Rouse B.T. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J. Immunol. 2012; 188 (7): 3434–3446. doi: 10.4049/jimmunol.1102602</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Liu R., Gao C., Chen H., Li Y., Jin Y., Qi H. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PloS One. 2017; 12 (4): e0173301. doi: 10.1371/journal.pone.0173301</mixed-citation><mixed-citation xml:lang="en">Liu R., Gao C., Chen H., Li Y., Jin Y., Qi H. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PloS One. 2017; 12 (4): e0173301. doi: 10.1371/journal.pone.0173301</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Suryawanshi A, Cao Z., Sampson J.F., Panjwani N. IL-17A– mediated protection against acanthamoeba keratitis. J. Immunol. 2015; 194 (2): 650–663. doi: 10.4049/jimmunol.1302707</mixed-citation><mixed-citation xml:lang="en">Suryawanshi A, Cao Z., Sampson J.F., Panjwani N. IL-17A– mediated protection against acanthamoeba keratitis. J. Immunol. 2015; 194 (2): 650–663. doi: 10.4049/jimmunol.1302707</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Carnt N., Montanez V.M., Galatowicz G., Veli N., Calder V. Tear cytokine levels in contact lens wearers with acanthamoeba keratitis. Cornea. 2017; 36 (7): 791–798. doi: 10.1097/ICO.0000000000001238</mixed-citation><mixed-citation xml:lang="en">Carnt N., Montanez V.M., Galatowicz G., Veli N., Calder V. Tear cytokine levels in contact lens wearers with acanthamoeba keratitis. Cornea. 2017; 36 (7): 791–798. doi: 10.1097/ICO.0000000000001238</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Suryawanshi A., Cao Z., Sampson J.F., Panjwani N. IL-17A-mediated protection against Acanthamoeba keratitis. J Immunol. 2015; 194 (2): 650–663. doi: 10.4049/jimmunol.1302707</mixed-citation><mixed-citation xml:lang="en">Suryawanshi A., Cao Z., Sampson J.F., Panjwani N. IL-17A-mediated protection against Acanthamoeba keratitis. J Immunol. 2015; 194 (2): 650–663. doi: 10.4049/jimmunol.1302707</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Qin X.H., Ma X., Fang S.F., Zhang Z.Z., Lu J.M. IL-17 produced by Th17 cells alleviates the severity of fungal keratitis by suppressing CX43 expression in corneal peripheral vascular endothelial cells. Cell Cycle. 2019; 18 (3): 274–287. doi: 10.1080/15384101.2018.1556059</mixed-citation><mixed-citation xml:lang="en">Qin X.H., Ma X., Fang S.F., Zhang Z.Z., Lu J.M. IL-17 produced by Th17 cells alleviates the severity of fungal keratitis by suppressing CX43 expression in corneal peripheral vascular endothelial cells. Cell Cycle. 2019; 18 (3): 274–287. doi: 10.1080/15384101.2018.1556059</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
